Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04875884 · ClinicalTrials.gov registry record · NA
Optimized MRI of Patients With Hip Arthroplasty
A NA study of Hip Arthropathy, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- NA
- Development phase
- 22
- Enrollment target
- 1
- Study location
NCT04875884 is a NA study of Hip Arthropathy that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 22 participants, below the 58-participant average among 4 other Hip Arthropathy trials with a reported enrollment target (62% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04875884, a NA study of Hip Arthropathy, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a single-center single-arm clinical trial with a paired design which compares the effectiveness of 3T MRI with (modified) and without (standard) radiofrequency pulse polarization optimization in reducing metal-related artifacts in patients with hip arthroplasty implants.
Conditions Studied
Interventions
- DEVICE Modified MRI
Study Locations (1)
New York
- NYU Langone Radiology - Center for Biomedical Imaging - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2022-08-11 |
| Est. Completion | 2027-12-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04875884
The ClinicalTrials.gov registry entry for NCT04875884 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 58-participant average among 4 other Hip Arthropathy trials with a reported enrollment target (62% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hip Arthropathy appearing as the primary indexed condition, and to 1 intervention - of which Modified MRI is the first listed.
NCT04875884 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT04875884 about?
NCT04875884 is a clinical study titled "Optimized MRI of Patients With Hip Arthroplasty". This is a single-center single-arm clinical trial with a paired design which compares the effectiveness of 3T MRI with (modified) and without (standard) radiofrequency pulse polarization optimization in reducing metal-related artifacts in patients with hip arthroplasty implants.
What is the current status of trial NCT04875884?
This trial is currently recruiting. It is a NA study. The enrollment target is 22 participants. The study started on 2022-08-11. Estimated completion is 2027-12-30.
What conditions does trial NCT04875884 study?
This clinical trial studies the following conditions: Hip Arthropathy.
What interventions are being tested in trial NCT04875884?
The interventions under investigation include: Modified MRI (DEVICE).
Who is sponsoring clinical trial NCT04875884?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04875884 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hip Arthropathy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.